High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus
about
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesThe role of the complement system in diabetic nephropathy.Comparison of inflammatory markers in non-dipper hypertension vs. dipper hypertension and in normotensive individuals: uric acid, C-reactive protein and red blood cell distribution width readingsHigh-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneLaboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammation.Association of high sensitivity C-reactive protein with the components of metabolic syndrome in diabetic and non-diabetic individuals.Periodontal inflamed surface area and C-reactive protein as predictors of HbA1c: a study in IndonesiaEvaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study.Multimeric stability of human C-reactive protein in archived specimens.The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix studyRelationship of the Serum CRP Level With the Efficacy of Metformin in the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis.Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.Triglyceride is a useful surrogate marker for insulin resistance in Korean women with polycystic ovary syndrome.Clinical potential of resistin as a novel prognostic biomarker for cellulitisPrevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study.Shift work and the risk of cardiovascular disease among workers in cocoa processing company, Tema.Prediction of Incident Diabetes in the Jackson Heart Study Using High-Dimensional Machine LearningSerum Total Sialic Acid and Highly Sensitive C-reactive Protein: Prognostic Markers for the Diabetic Nephropathy.Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitusPioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance.Cardioprotective role of insulin: Advantage analogues.Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosisImpact of clinical and procedural factors upon C reactive protein dynamics following transcatheter aortic valve implantation.Association between hs-CRP Levels and the Outcomes of Patients with Small-Artery OcclusionStudy of atherogenic lipid profile, high sensitive C-reactive protein neurological deficit and short-term outcome in stroke subtypesSerum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus.High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care centerThe interplay between inflammation, physical activity and metabolic syndrome in a remote male geriatric community in Southern Taiwan: the Tianliao Old People (TOP) study 03.Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study.Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: An evidence linking oxidative stress, inflammation and glycemic control.Metabolic inflammation: connecting obesity and insulin resistance.Is osteoarthritis a metabolic disorder?Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran.Serum uric acid levels and inflammatory markers with respect to dipping status: A retrospective analysis of hypertensive patients with or without chronic kidney disease.Evaluation of risk markers fluctuation during an initial therapy with rosiglitazon in patients suffering from metabolic syndrome.Prophylactic Add-on Antiplatelet Therapy in Chronic Kidney Disease With Type 2 Diabetes Mellitus: Comparison Between Clopidogrel and Low-dose Aspirin.Resting Heart Rate Variability, Inflammation, and Insulin Resistance in Overweight and Obese Adolescents.Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
P2860
Q26828855-69876A8B-6F89-4290-AD3A-62B2C2088BC9Q30235417-1C90A1BA-8C3E-40B0-913B-62C8C18445F6Q33941318-C3A5B3B3-13A8-4446-8CEA-D2B2BC9A4F32Q33979763-D6AA621B-F96D-423C-9E9E-D7B42AB25E49Q33979779-9C31C5A6-893A-473F-BFA1-856339A225B7Q34030401-262EE49D-12B8-428F-8BA9-82DD5C6C2411Q34052033-0FA397DF-2B85-4980-BC2B-5A7DCAB99586Q34612954-F322FD3B-FD89-44CF-8227-FABC3E50A067Q34629451-55CEC01E-A601-449F-B615-A72A746458C4Q35076036-22A71A14-DD44-41E0-B046-087455F3B4F5Q35296963-046F26D2-F4F7-4A18-B8D5-D0E37AF94E02Q35337177-FE784188-287A-41EB-92BF-54ABA8CE5239Q35421838-1AF81268-8DC7-4187-9ADC-8D5BA7875EF9Q35754330-7533C54F-05D6-4466-8D73-C0454CDF94BDQ35834883-806AEA24-91E3-4184-A913-005C0A9A291DQ35872926-A0999281-F5C4-4978-9714-A53BAB308CC2Q36160422-F8F577FC-B309-4D7B-A28C-A5E95AEF4A96Q36671832-D876A776-869B-4A0E-B659-8471E298EB90Q36785475-82CCD544-EC27-40BF-9CD9-54DF8B319B7FQ36909303-F391E5BD-84B0-4DA5-8DC9-1CA0AC483EB7Q36915215-76C9DDB7-A284-4006-A197-EAEBFF97A524Q36938100-A89E65D8-8FE0-430D-BCAC-251BAE90DD02Q36990610-9B3DBC7C-9F17-4D27-B456-6E81DDB608BDQ37121184-CB0AEAE3-71B2-421D-A456-087A7DD63E0EQ37159284-9BF60131-85C8-444E-BCFF-39C15F1D21B6Q37263432-6142CCF8-60B1-45D6-AEC7-EDC7E1AF6A73Q37271531-B5056C99-A0F8-458C-A9F9-0113CE9181A6Q37311787-7C19147F-084A-40CA-B3F9-3641B9FD885BQ37367559-0C8E4AF7-E8A1-45A9-9E27-CB510AF707B4Q37381433-E189D873-E337-44C5-B280-1C3CE011E32BQ37557757-0B8BF495-AFDF-4BC8-B76D-42EE99C1E750Q38029782-1B184C94-EBF3-45CC-9F52-957B469E8662Q38547980-1A8AF22B-B5E3-48C4-85F0-125F15BA72E6Q39428853-7E7196EB-0601-43B5-8A5A-786C9597CD7EQ40661201-E915B042-1194-4813-BB47-5D72C2043901Q41698422-B9F2407E-CDFC-4F0C-9781-7C284D5008DDQ41832998-058176EA-BD10-4360-A850-098D6F955F0CQ41936848-25F7F0FF-9FBE-4C69-B67F-6B6E16035CFEQ41938287-CC185286-D4E9-44F7-AD6B-651ADE744046Q42240864-29B63D34-EC75-4E10-9148-369E9B9E9191
P2860
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@ast
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@en
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@nl
type
label
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@ast
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@en
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@nl
prefLabel
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@ast
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@en
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@nl
P3181
P356
P1476
High-sensitivity C-reactive pr ...... atients with diabetes mellitus
@en
P2093
Thomas Forst
P3181
P356
10.1089/DIA.2006.8.28
P407
P577
2006-02-01T00:00:00Z